S100A9 and laryngotracheoesophageal cleft: Many of them reported that ALDH1 inhibition can reduce tumor growth and treatment resistance in LC, such as the S100A9-ALDH1A1-retinoic acid signaling pathway-targeting study that showed a reduction in recurrence in LC [94].